Beyond the Ordinary Beyond the Obvious
Credit: mi_viri | stock.adobe.com Key Takeaways: Nerandomilast Phase III Trial Data Nerandomilast Demonstrates Statistically Significant FVC Preservation in…
In a recent video interview with Applied Clinical Trials, Michel van Harten, MD, CEO, myTomorrows, discussed the integration…
Credit: Dr_Microbe | stock.adobe.com. Key Takeaways: Xtandi in mHSPC Long-Term Survival Confirmed. Five-year results from the Phase III…
Image Credit: © NicoElNino – stock.adobe.com Key takeaways Digital intake must be the default to ensure quality and…
In a recent video interview with Applied Clinical Trials, Michel van Harten, MD, CEO, myTomorrows, discussed the integration…
Image Credit: © Pixel-Shot – stock.adobe.com Key takeaways Susvimo sets a new standard for long-acting ophthalmic treatments: With…
Credit: Araki Illustrations | stock.adobe.com Key Takeaways FDA Panel Votes Against Columvi-GemOx sBLAThe FDA’s Oncologic Drugs Advisory Committee…
Image Credit: © JHVEPhoto – stock.adobe.com Key takeaways Placebo-controlled trials now required for low-risk groups: FDA will require…
In a recent video interview with Applied Clinical Trials, Michel van Harten, MD, CEO, myTomorrows, discussed the integration…
Image Credit: © photon_photo – stock.adobe.com Key takeaways Simplify with purpose: prioritize what adds value: Modern trials are…
In a recent video interview with Applied Clinical Trials, Michael Liu, medical student and researcher at Harvard Medical…
Image Credit: © putilov_denis – stock.adobe.com Key Takeaways Community trials drive access and diversity: Embedding clinical trials in…
In a recent video interview with Applied Clinical Trials, Michael Liu, medical student and researcher at Harvard Medical…
Credit: MohammedElAmine | stock.adobe.com Key Takeaways from the Phase III KEYNOTE-B96/ENGOT-ov65 Trial Keytruda Shows First OS Benefit in…
In a recent video interview with Applied Clinical Trials, Michael Liu, medical student and researcher at Harvard Medical…
Credit: GoodIdeas | stock.adobe.com Key Takeaways of the TAK-861-2001 Trial Clinically Meaningful Efficacy: In the Phase II TAK-861-2001…
Image Credit: © JHVEPhoto – stock.adobe.com Key takeaways 1. Regulatory milestone for rare tumors: Merck’s Welireg received FDA…
In a recent video interview with Applied Clinical Trials, Michael Liu, medical student and researcher at Harvard Medical…
Credit: Sebastian Kaulitzki | stock.adobe.com Key takeaways 1. Accelerated approval based on Phase II data: Emrelis received FDA…
Sciatilief review mention how quickly it works Living with nerve pain can be a relentless struggle, often affecting…
The calendar year of 2025 has brought many new challenges to the clinical research industry. Earlier in the…
Credit: David A Litman | stock.adobe.com Long-term overall survival (OS) data from the Phase III APHINITY trial (NCT01358877)…
Image Credit: © photon_photo – stock.adobe.com Novo Nordisk has shared positive trial results from the Phase III REAL8…
In a recent video interview with Applied Clinical Trials, Krinx Kong, chief commercial officer, Cognivia, discussed the potential…
Image Credit: © putilov_denis – stock.adobe.com eCOA (electronic clinical outcome assessment) systems have become essential in modern clinical…
Credit: Sebastian Kaulitzki | stock.adobe.com Long-term extension (LTE) data from the Phase IIb/III QUASAR trial (NCT04033445) program show…
Credit: Valerii Apetroaiei | stock.adobe.com Topline results from the Phase III DESTINY-Breast11 trial (NCT05113251) show that Enhertu (trastuzumab…
Credit: syahrir | stock.adobe.com Updated data from the pivotal Phase III ELATIVE trial (NCT04526665) show Iqirvo (elafibranor) significantly…
Image Credit: © Pixel-Shot – stock.adobe.com Boehringer Ingelheim has announced the start of the JADE Phase II clinical…
Image Credit: © Matthieu – stock.adobe.com AstraZeneca has shared positive results from its Phase III POTOMAC trial of…
Credit: Yurii Kibalnik | stock.adobe.com Top-line results from the Phase III GLISTEN trial (NCT04950127) show that the novel…
In a recent video interview with Applied Clinical Trials, Krinx Kong, chief commercial officer, Cognivia, discussed the potential…
In a recent video interview with Applied Clinical Trials, Krinx Kong, chief commercial officer, Cognivia, discussed the potential…
David Nickerson, head of clinical quality management at EMD Serono, executive sponsor of TransCelerate’s ICH E6(R3) Initiative &…
Image Credit: © photon_photo – stock.adobe.com Gilead has announced final data from its Phase III MYR301 clinical trial…
Credit: ibreakstock | stock.adobe.com Results from the Phase III MUSA trial show that in women with moderate to…
Image Credit: © Matthieu – stock.adobe.com Nanobiotix has announced full results from a Phase I study evaluating its…
Image Credit: © putilov_denis – stock.adobe.com The role of electronic data capture (EDC) systems in clinical trials looks…
Image Credit: © Sebastian Kaulitzki – stock.adobe.com AstraZeneca has announced positive results from the Phase III KALOS and…
In a recent video interview with Applied Clinical Trials, C.K. Wang, MD, chief medical officer, COTA, discussed a…
Credit: peterschreiber.media | stock.adobe.com Results of the Phase III MATINEE trial (NCT04133909) show that Nucala (mepolizumab) produced a…
Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life…
Credit: Peter Hansen | stock.adobe.com Weekly semaglutide was found to significantly improve steatohepatitis and fibrosis while enhancing metabolic…
Unlock Commercial Growth through Data-Driven Patient and HCP Insights Podcast
Image Credit: © photon_photo – stock.adobe.com Clinical trials are responsible for generating some of the most important evidence…
In a recent video interview with Applied Clinical Trials, C.K. Wang, MD, chief medical officer, COTA, discussed a…
Image Credit: © yodiyim – stock.adobe.com The FDA has approved Satsuma’s STS101 dihydroergotamine (DHE) nasal powder under the…
In a recent video interview with Applied Clinical Trials, C.K. Wang, MD, chief medical officer, COTA, discussed a…
Image Credit: © JHVEPhoto – stock.adobe.com The FDA has approved Johnson & Johnson’s IMAAVY (nipocalimab-aahu) for the treatment…
In a recent video interview with Applied Clinical Trials, C.K. Wang, MD, chief medical officer, COTA, discussed a…
Image Credit: © Sebastian Kaulitzki – stock.adobe.com Boehringer Ingelheim has shared new data from the Phase Ib Beamion…
Image Credit: © photon_photo – stock.adobe.com Clinical research sites are overburdened by the growing complexity of trial protocols,…
Image Credit: © Matthieu – stock.adobe.com Pfizer has shared new data from the Phase III CREST clinical trial…
Industry experts from Precision for Medicine will share practical strategies for navigating the complexities of sample management in…
Credit: freshidea | stock.adobe.com Data from the Phase III GEMINI 1 (NCT04410978) and GEMINI 2 trials (NCT04410991) show…
Image Credit: © photon_photo – stock.adobe.com Patient-reported outcomes (PROs) have long served as an essential tool for understanding…
Credit: Yurii Kibalnik | stock.adobe.com A regimen of Rinvoq (upadacitinib) with a 26-week glucocorticoid taper showed superior efficacy…
Credit: Andrey Popov | stock.adobe.com Findings from the 12-week Phase II Advance-HTN trial (NCT05769608) show that lorundrostat significantly…
Image Credit: © Dr_Microbe – stock.adobe.com Roche has shared additional findings from the Phase III CENTERSTONE clinical trial…
In a recent video interview with Applied Clinical Trials, Rob Jones, product manager, TMF practice area, Pharmalex, discussed…
Credit: Thipphaphone | stock.adobe.com Brensocatib was found to significantly lower the annualized rate of pulmonary exacerbations and lung…
In a recent video interview with Applied Clinical Trials, Rob Jones, product manager, TMF practice area, Pharmalex, discussed…
Image Credit: © freshidea – stock.adobe.com Bristol Myers Squibb has shared results from its Phase III ARISE trial…
In a recent video interview with Applied Clinical Trials, Rob Jones, product manager, TMF practice area, Pharmalex, discussed…
In a recent video interview with Applied Clinical Trials, Rob Jones, product manager, TMF practice area, Pharmalex, discussed…
Credit: Sebastian Kaulitzki | stock.adobe.com Interim data from the Phase III DESTINY-Breast09 trial (NCT04784715) found that the combination…
Image Credit: Adobe Stock Images/Lars Neumann Topline findings from Gilead’s Phase III ASCENT-04/KEYNOTE-D19 study found that the combination…
In a recent video interview with Applied Clinical Trials, Rob Jones, product manager, TMF practice area, Pharmalex, discussed…
Bridging Data & Disparities: The Power of SDOH in the Life Sciences Industry
Credit: blacksalmon | stock.adobe.com Results from the Phase IV DapaTAVI trial (NCT04696185) show that the addition of Farxiga…
Credit: MarijaBazarova | stock.adobe.com Long-term safety and efficacy clinical trial data (NCT03307980) for patients with hemophilia B administered…
Credit: wutipong | stock.adobe.com Findings from the Phase III MINT clinical trial (NCT04524273) show that Uplizna (inebilizumab) produced…
Image Credit: © Aerial Mike – stock.adobe.com Alector has announced the completion of enrollment for its Phase II…
In a recent video interview with Applied Clinical Trials, Derek Ansel, vice president, therapeutic strategy lead, rare disease,…
Image Credit: © Mnt – stock.adobe.com Eli Lilly has shared positive Phase III clinical trial data of its…
In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses…
Devin Ridgley, PhD, Director, Project Management, Medical Device and Diagnostics Research, ICON JoAnne Bronikowski, BSCS, RAC, Senior Manager,…
In a recent video interview with Applied Clinical Trials, Derek Ansel, vice president, therapeutic strategy lead, rare disease,…
Credit: Milan Lipowski | stock.adobe.com Johnson & Johnson has shared positive data from a subgroup analysis of the…
In a recent video interview with Applied Clinical Trials, Derek Ansel, vice president, therapeutic strategy lead, rare disease,…
In a recent video interview with Applied Clinical Trials, Derek Ansel, vice president, therapeutic strategy lead, rare disease,…
Ken Getz, MBA, Executive Director and Research Professor, Tufts Center for the Study of Drug Development, Tufts University…
February 13th 2025 Article Dr. Peter Wahl, MLA, MS, ScD, VP and Global Head of Scientific Affairs at…
Image Credit: © Murrstock – stock.adobe.com The monitoring of key risk indicators (KRIs) is an established form of…
Rebecca Johnson, PhD, Clinical Research Recruitment and Inclusion Executive and Strategist Efforts to make sustainable change toward more…
Amid new government directives around diversity, equity, and inclusion programs in the US, our April issue explores the…
Applied Clinical Trials: April 2025 Interactive Digital Edition The Impact of DEI Ban On Clinical Research Ecosystem Tapping…
In a recent video interview with Applied Clinical Trials, Theirry Escudier, Portfolio Lead, Pistoia Alliance, discussed the alliance’s…
Stacy Hurt, Chief Patient Officer, Parexel As a patient advocate and caregiver, I’m excited and bullish about the…
In a recent video interview with Applied Clinical Trials, Theirry Escudier, Portfolio Lead, Pistoia Alliance, discussed the alliance’s…
Oncology clinical trials are increasingly complex, driven by rising data volumes, regulatory requirements, and inefficiencies in manual data…
Digital measures offer new insights into human health but require complex, multi-stakeholder development. Are they worth the effort?…
Hugo Stephenson, MD, Co-Founder and Executive Chair, TrialScreen With 40% of young people now getting their news from…
Credit: fusssergei | stock.adobe.com Findings from the Phase IIIb APEX trial (NCT04882098) found that Tremfya (guselkumab) produced a…
Credit: ralwel | stock.adobe.com Roche has announced results from the Phase III MUSETTE clinical trial of high-dose Ocrevus…
In a recent video interview with Applied Clinical Trials, Craig Lipset, co-chair, Decentralized Trials & Research Alliance (DTRA),…
In a recent video interview with Applied Clinical Trials, Craig Lipset, co-chair, Decentralized Trials & Research Alliance (DTRA),…
In a recent video interview with Applied Clinical Trials, Craig Lipset, co-chair, Decentralized Trials & Research Alliance (DTRA),…
In a recent video interview with Applied Clinical Trials, Craig Lipset, co-chair, Decentralized Trials & Research Alliance (DTRA),…
In a recent video interview with Applied Clinical Trials, Craig Lipset, co-chair, Decentralized Trials & Research Alliance (DTRA),…
Image Credit: © ckybe – stock.adobe.com One-year data from the SmartfIRE trial show that Johnson & Johnson’s (J&J)…
Credit: santoelia | stock.adobe.com Results from the Phase III SOUL trial (NCT03914326) published by The New England Journal…
Image Credit: © Jakub Krechowicz – stock.adobe.com Healthcare research represents a frontier where new drugs, behavioral interventions, diagnostics,…
Credit: Artur | stock.adobe.com Findings from the Phase III API-CAT trial (NCT03692065) show that extended anticoagulant therapy with…
Image Credit: © Egor – stock.adobe.com Palatin has announced positive results from its BMT-801 Phase II clinical trial…
Credit: Rasi | stock.adobe.com Data from the Phase IIb PURSUIT trial (NCT06173570) found that AZD0780, a novel proprotein…
Image Credit: © photon_photo – stock.adobe.com Merck has announced positive results from the Phase III ZENITH clinical trial…
Credit: Chudapa | stock.adobe.com Results from the Phase II ALPACA trial (NCT05565742) published by The New England Journal…
Image Credit: © putilov_denis – stock.adobe.com Merck has shared data from the 3475A-D77 Phase III clinical trial of…
In a recent video interview with Applied Clinical Trials, Rachael Higgins, chief commercial officer, PicnicHealth, discussed the company’s…
In a recent video interview with Applied Clinical Trials, Rachael Higgins, chief commercial officer, PicnicHealth, discussed the company’s…
In a recent video interview with Applied Clinical Trials, Rachael Higgins, chief commercial officer, PicnicHealth, discussed the company’s…
In a recent video interview with Applied Clinical Trials, Craig Lipset, co-chair, Decentralized Trials & Research Alliance (DTRA),…
Credit: Naeblys | stock.adobe.com Findings from the Phase III MITIGATE trial (NCT04540497) show the efficacy of Uplizna (inebilizumab)…
Image Credit: © Dr_Microbe – stock.adobe.com The FDA has approved Novartis’ radioligand therapy Pluvicto (lutetium Lu 177 vipivotide…
Credit: adrian_ilie825 | stock.adobe.com Findings from the Phase III FOCUS trial (NCT05972044) show solriamfetol produced a significant reduction…
ACT: What advancements do you foresee for Medable AI and Medable Studio, and how might these innovations change…
Credit: ra2 studio | stock.adobe.com Clinical data is the cornerstone of progress in high-stakes pharmaceutical research and development.…
Image Credit: © iDoPixBox – stock.adobe.com Johnson & Johnson has shared new, positive data from the Phase III…
ACT: Medable has played a pivotal role in decentralized and digital clinical trials globally. How do you see…
Credit: ralwel | stock.adobe.com Results from the Phase III HERCULES (NCT04411641) trial and Phase III GEMINI 1 (NCT04410978)…
Credit: Axel Kock | stock.adobe.com Data from the Phase III VERITAC-2 trial (NCT05654623) found that vepdegestrant (ARV-471) monotherapy…
The quality of study coordinator work is important to investigative sites, study sponsors, CROs, regulators, and patients. Site…
In a recent video interview with Applied Clinical Trials, Cameron Breze, product manager, Inovalon, discussed challenges in patient…
In a recent video interview with Applied Clinical Trials, Cameron Breze, product manager, Inovalon, discussed challenges in patient…
February 13th 2025 Article Dr. Peter Wahl, MLA, MS, ScD, VP and Global Head of Scientific Affairs at…
ACT: Medable has achieved impressive results, such as 90% eCOA adherence. How do you ensure such high levels…
Credit: urwa | stock.adobe.com Maintenance treatment with Tecentriq (atezolizumab) was not found to produce a significant improvement in…
Paul Mancinelli, PhD, is the Chief Technology Officer of WCG In today’s rapidly evolving technological landscape, robust datasets…
Image Credit: © Rochu_2008 – stock.adobe.com Novartis has announced positive results from its Phase III clinical trial program…
Credit: bizoo_n | stock.adobe.com The New Normal Five years ago, COVID-19 was declared a global pandemic, marking the…
Image Credit: Adobe Stock Images/Lila Patel Immunovant has shared positive results of its batoclimab in a Phase III…
Credit: Matthieu | stock.adobe.com Findings from the Phase III DIPPER trial (NCT03427827) published by JAMA show that adjuvant…
Kristin Tolbert, Associate VP of Health Equity Strategy at Jumo Health Pregnant women have long been excluded from…
Credit: Yurii Kibalnik | stock.adobe.com Based on data from the Phase II DAHLIAS (NCT04968912) trial, the FDA has…
Image Credit: © Dr_Microbe – stock.adobe.com Genmab has shared positive results from the Phase I/II RAINFOL-01 clinical trial…
In a recent video interview with Applied Clinical Trials, Cameron Breze, product manager, Inovalon, discussed challenges in patient…
In a recent video interview with Applied Clinical Trials, Yael Elish, founder, CEO, StuffThatWorks; and Julie Ross, president,…
In a recent video interview with Applied Clinical Trials, Yael Elish, founder, CEO, StuffThatWorks; and Julie Ross, president,…
In a recent video interview with Applied Clinical Trials, Yael Elish, founder, CEO, StuffThatWorks; and Julie Ross, president,…
In a recent video interview with Applied Clinical Trials, Yael Elish, founder, CEO, StuffThatWorks; and Julie Ross, president,…
Credit: Alex Papp | stock.adobe.com Data from the Phase III BRAVE-AA-PEDS (NCT05723198) trial show that adolescents with severe…
Image Credit: © putilov_denis – stock.adobe.com Digital technologies have significantly transformed the landscape of clinical trials, revolutionizing the…
Credit: RAJCREATIONZS | stock.adobe.com Results from an ongoing Phase I trial have shown the potential of once-yearly intramuscular…
Image Credit: © Ezume Images – stock.adobe.com Merck has announced positive results from two Phase III clinical trials…
Image Credit: © Sebastian Kaulitzki – stock.adobe.com Johnson & Johnson has shared positive results from multiple clinical trials…
Credit: Lisa | stock.adobe.com A meta-analysis of 11 randomized and nonrandomized clinical trials shows significant benefits with Padcev…
Credit: Milan Lipowski | stock.adobe.com Findings from the Phase III POETYK PsA-2 trial (NCT04908189) show Sotyktu (deucravacitinib) produced…
Zahiah (Zee Zee) Gueddar, Senior Director, Commercialization, IQVIA Technologies Melissa Mooney, Director Solution Engineering, IQVIA Patient Suite, IQVIA…
Vicky Marriott, Head of Statistics at Phastar As we marked International Women’s Day on March 8, we all…
Credit: Toowongsa | stock.adobe.com Precision medicine is poised to transform healthcare as we’ve known it, from the earliest…
In a recent video interview with Applied Clinical Trials, Iddo Peleg, CEO and co-founder at Yonalink, discussed the…
Credit: stas_malyarevsky | stock.adobe.com A cost-effectiveness analysis of results from the Phase III ENGOT-cx11/GOG-3407/KEYNOTE-A18 clinical trial (NCT04221945) found…
In a recent video interview with Applied Clinical Trials, Iddo Peleg, CEO and co-founder at Yonalink, discussed the…
In a recent video interview with Applied Clinical Trials, Iddo Peleg, CEO and co-founder at Yonalink, discussed the…
Credit: Crystal light | stock.adobe.com Results from the Phase III MATTERHORN trial (NCT04592913) found that perioperative treatment with…
Image Credit: © putilov_denis – stock.adobe.com Clinical trials are becoming increasingly complex, with trial cycle times rising by…
Image Credit: © photon_photo – stock.adobe.com Tris Pharma has announced positive, topline results from its ALLEVIATE-2 Phase III…
Credit: ABUL | stock.adobe.com Findings from the Phase III REMIX-1 (NCT05030311) and REMIX-2 (NCT05032157) clinical trials show that…
In a recent video interview with Applied Clinical Trials, Iddo Peleg, CEO and co-founder at Yonalink, discussed the…
ACT: With some judges indicating that the NIH funding freeze may be illegal, are there grounds for the…
Credit: Prostock-studio | stock.adobe.com Tezspire (tezepelumab-ekko; Amgen and AstraZeneca) was found to significantly decrease the size of nasal…
ACT: In addition to the NIH funding cuts, how do you see the clinical trials industry navigating other…
ACT: What should stakeholders have top of mind as they find new ways to effectively navigate and continue…
Image Credit: © photon_photo – stock.adobe.com Obstacles for pharma, biotech, and CROs Contract research organizations (CROs), biotech companies,…
In a recent video interview with Applied Clinical Trials, Vera Pomerantseva, director of product management, RBQM, eClinical Solutions,…
Credit: David A Litman | stock.adobe.com Results from the Phase III GEMSTONE-303 trial (NCT03802591) show that sugemalimab combined…
In a recent video interview with Applied Clinical Trials, Vera Pomerantseva, director of product management, RBQM, eClinical Solutions,…
Credit: Ocskay Mark | stock.adobe.com The Phase III RELATIVITY-098 trial (NCT05002569) of Opdualag (nivolumab and relatlimab-rmbw) in the…
In a recent video interview with Applied Clinical Trials, Vera Pomerantseva, director of product management, RBQM, eClinical Solutions,…
Credit: Tierney | stock.adobe.com The pharmaceutical industry is making significant strides driven by digital innovation and artificial intelligence…
Image Credit: © Tada Images – stock.adobe.com The National Institutes of Health (NIH) has partially lifted a freeze…
Credit: magicmine | stock.adobe.com Results from the Phase III PRESTIGE-AF trial (NCT03996772) found that treatment with direct oral…
Buy ZYN Online When you buy ZYN online in the Philippines, you get access to a wide range…
Sponsored by uMotif In this video, uMotif CEO Steve Rosenberg discusses key trends shaping the clinical trial landscape,…
Image Credit: © Egor – stock.adobe.com Artificial intelligence (AI) is the biggest transformation in life sciences in the…
Image Credit: © Sebastian Kaulitzki – stock.adobe.com Teva and Sanofi have shared additional data from the Phase IIb…
Ozempic 有何不同 Saxenda 和 Ozempic 是我們香港醫療中心最暢銷的藥物之一，許多患者經常詢問這兩款藥物的區別，以及哪種更適合自己的需求。Saxenda 和 Ozempic 都屬於胰高血糖素樣肽-1（GLP-1）受體激動劑，這類藥物的主要作用是幫助減重和改善血糖控制。然而，儘管它們有相似的機制，卻在適應症、使用方式和減重效果等方面有所不同，因此患者應根據自身的健康狀況和需求來選擇最合適的藥物。 Saxenda 的主要成分是 liraglutide，最初是用於治療 2 型糖尿病的 Victoza，但後來被批准為減重專用藥物，因此 Saxenda 主要適用於體重指數（BMI）≥ 30…
Credit: Sebastian Kaulitzki | stock.adobe.com Positive findings from the ongoing Phase III CheckMate -8HW trial (NCT04008030) resulted in…
ACT: Could you share real-world use cases where this technology has significantly accelerated clinical development, improved data integrity,…
Das: Effective and well-designed clinical trials is essential for the commercialization stage, and particularly when it comes to…
Credit: putilov_denis | stock.adobe.com Introduction As the gold standard for clinical research, randomized controlled trials (RCTs) are central…
Lightship focuses on patient accessibility and centricity in clinical trials, ensuring the patient experience is a positive one.…
In a recent video interview with Applied Clinical Trials, Dominique Demolle, CEO of Cognivia, discussed challenges in improving…
In a recent video interview with Applied Clinical Trials, Dominique Demolle, CEO of Cognivia, discussed challenges in improving…
ACT: What are Phastar’s key objectives for attending SCOPE 2025, and how do you see the conference shaping…
Credit: Saiful52 | stock.adobe.com Results from the Phase III ASTRO trial (NCT05528510) found that treatment with subcutaneous (SC)…
ACT: You were a part of panel discussion on start-up companies. Can you briefly discuss what the panel…
Credit: jarun011 | stock.adobe.com A regimen of fixed-duration Calquence (acalabrutinib; AstraZeneca) plus venetoclax, with or without Gazyva (obinutuzumab),…
In a recent video interview with Applied Clinical Trials, Dominique Demolle, CEO of Cognivia, discussed challenges in improving…
Credit: Sebastian Kaulitzki | stock.adobe.com A final analysis of survival data from the Phase III CheckMate -816 trial…
ACT: What types of partnerships—whether with CROs, technology vendors, or patient advocacy groups—do you see as crucial for…
In a recent video interview with Applied Clinical Trials, Dominique Demolle, CEO of Cognivia, discussed challenges in improving…
ACT: What are your primary objectives for attending SCOPE 2025, and what insights are you hoping to gain…
Credit: Milan Lipowski | stock.adobe.com Newly released five-year data from the POETYK PSO long-term extension (LTE) trial show…
ACT: What are some barriers that stakeholders struggle to overcome when they want to implement more DCT approaches?…
February 3rd 2025 Article This white paper presents findings from the PurpleLab Migraine Study, which leverages real-world data…
February 13, 2025 Publication Video Sponsored Jennifer Kim, PhD, assistant research professor, Tufts School of Medicine, Tufts Center…
Lightship focuses on patient accessibility and centricity in clinical trials, ensuring the patient experience is a positive one.…
ACT: With Veeva’s 2025 Clinical Data Trend Report now available, what are some key trends in clinical data…
admin